Kerr, J R, Christian, P, Hodgetts, A et al. · Journal of clinical pathology · 2007 · DOI
This review describes an organized effort by researchers to better understand ME/CFS by studying genes and immune system changes in patients' blood. The goal is to find biological markers that can reliably diagnose the illness and to test new treatments that might help. Researchers are using advanced technology to look at thousands of genes at once to find patterns specific to ME/CFS.
This research addresses fundamental gaps in ME/CFS by establishing a coordinated framework to identify biological markers for diagnosis—currently lacking—and to test disease-modifying treatments. A reliable diagnostic test and validated biomarkers would reduce diagnostic delays, improve patient care, and enable better clinical trial design for future therapies.
This review does not provide evidence that any specific gene signature or biomarker definitively causes ME/CFS or has been successfully validated as disease-specific. The proposed treatments (interferon-beta and TNF-alpha inhibitors) are discussed as candidates for trials but are not yet proven effective in ME/CFS patients. The identification of immune dysfunction does not establish whether it is primary pathology or secondary to another process.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
The first block is for the primary paper and is the citation you should use in research work. The atlas-snapshot line only applies if you are specifically referring to this atlas’s reading of the paper on the date shown.
Primary citation
Kerr, J R, Christian, P, Hodgetts, A, Langford, P R, Devanur, L D, Petty, R, et al. (2007). Current research priorities in chronic fatigue syndrome/myalgic encephalomyelitis: disease mechanisms, a diagnostic test and specific treatments.. Journal of clinical pathology. https://doi.org/10.1136/jcp.2006.042374
BibTeX
@article{mecfsatlas-kerr-2007-current-research,
author = {Kerr, J R and Christian, P and Hodgetts, A and Langford, P R and Devanur, L D and Petty, R and Burke, B and Sinclair, L I and Richards, S C M and Montgomery, J and McDermott, C R and Harrison, T J and Kellam, P and Nutt, D J and Holgate, S T and Collaborative Clinical Study Group},
title = {Current research priorities in chronic fatigue syndrome/myalgic encephalomyelitis: disease mechanisms, a diagnostic test and specific treatments.},
journal = {Journal of clinical pathology},
year = {2007},
doi = {10.1136/jcp.2006.042374},
note = {PubMed: 16935968},
url = {https://www.mecfsatlas.com/evidence/kerr-2007-current-research},
}Atlas snapshot reference
ME/CFS Atlas. Generator v1 / Scanner v1.4 / policy v0.1. Accessed 2026-05-30. https://www.mecfsatlas.com/evidence/kerr-2007-current-research
Contribute
Private, reviewed by a human. Not a public comment thread.